Items where Author is "Aebi, Stefan"
Jump to: Article Number of items: 3. ArticlePagani, Olivia and Klingbiel, Dirk and Ruhstaller, Thomas and Nole, Franco and Eppenberger-Castori, Serenella and Oehlschlegel, Christian and Bernhard, Jürg and Brauchli, Peter and Hess, Dagmar and Mamot, Christoph and Munzone, Elisabetta and Pestalozzi, Bernhard C. and Rabaglio, Manuela and Aebi, Stefan and Ribi, Karin and Rochlitz, Christoph and Rothgiesser, Karin and Thürlimann, Beat and von Moos, Roger and Zaman, Khalil and Goldhirsch, Aron and Swiss Group for Clinical Cancer, Research. (2017) Do all patients with advanced HER2 positive breast cancer need upfront-chemo when receiving trastuzumab? Randomized phase III trial SAKK 22/99. Annals of Oncology, 28 (2). pp. 305-312. Huober, Jens and Baumann, Michael and Rochlitz, Christoph and Aebi, Stefan and Güth, Uwe and von Moos, Roger and Müller, Andreas and von Rohr, Lukas and Widmer, Isabelle and Thürlimann, Beat. (2011) Trastuzumab treatment beyond progression in advanced breast cancer : patterns of care in six Swiss breast cancer centers. Oncology, 81 (3-4). pp. 160-166. Antonov, Janine and Popovici, Vlad and Delorenzi, Mauro and Wirapati, Pratyaksha and Baltzer, Anna and Oberli, Andrea and Thürlimann, Beat and Giobbie-Hurder, Anita and Viale, Giuseppe and Altermatt, Hans Jörg and Aebi, Stefan and Jaggi, Rolf. (2010) Molecular risk assessment of BIG 1-98 participants by expression profiling using RNA from archival tissue. BMC cancer, Vol. 10 , 37. p. 37. |
